Medicine
Nayzilam 5 mg/0.1 mL nasal spray
Nayzilam 5 mg/0.1 mL nasal spray is a prescription medicine containing Midazolam for nasal use, marketed by UCB, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 20°C to 25°C (68°F to 77°F). Excursions…
Key facts
- Active ingredient (INN)
- Midazolam
- Brand
- Nayzilam
- Strength
- 5 mg/0.1 mL
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 2 blister pack
- Marketing authorisation holder
- UCB
- Manufacturer
- UCB
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 20°C to 25°C (68°F to 77°F). Excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05CD08 Midazolam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 May 2019
- Identifiers
- RxCUI 2173494, 2173500DailyMed set ID 2b29422e-54d5-4a49-8522-e9cf752368c3NDC 50474-500Application NDA211321
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 blister pack in 1 carton / 1 vial, single-dose in 1 blister pack / .1 mL in 1 vial, single-dose | 50474-500-15 | UCB | 17 May 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Midazolam
Clinical summary
Midazolam is a benzodiazepine indicated for the acute treatment of intermittent, among other approved uses. It is available as injection, syrup and nasal spray for intravenous, intramuscular and oral use. MedsAcross supplies Midazolam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MidazolamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nayzilam prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Buccolam: European public assessment report (EPAR) · European Medicines Agency
Need Nayzilam 5 mg/0.1 mL nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.